| SEEL Snapshot | |
|---|---|
| Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel technologies and therapies for the treatment of central nervous system, respiratory, and other disorders. The company is headquartered in New York, New York. | |
| VALUATION DATA | |
| Market Capitalization | $4,474,900 | Price to Sales | 0.00 |
| Earnings per Share | $-7.7300 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $0.3010 |
| 52 Week High | $2.87 |
| 52 Week Low | $15.1 |
| 50-Day Moving Average | $220.46 |
| 200-Day Moving Average | $-0.465 |
| All data are from Alpha Vantage as of today. For more infomation on SEEL see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search